Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Dosing for Diabetic Macular Edema
NCT03608839Phase 2Completed
- Sponsor
- Universidade Federal de Pernambuco
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexamethasone in diabetic macular edema (DME) (3 arms), sponsored by Universidade Federal de Pernambuco. Primary endpoint: Macular Thickness at 3 Days After Intravitreous Dexamethasone. Started May 2016; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03608839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03608839.